VCAM-1 Promotes Angiogenesis of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Trauma-Induced Osteonecrosis of the Femoral Head by Regulating the Apelin/CCN2 Pathway

<div>Apelin-13 inhibits the migration and angiogenesis of VCAM-1-BMSCs: (a) the relative protein expression of APLN and CCN2 after treatment with Apelin-13; (b) cell counts of migration after treatment with Apelin-13; (c) typical image of tube formation after treatment with Apelin-13; (d) junctions of angiogenic network after treatment with Apelin-13; (e) total branching length of angiogenic network after treatment with Apelin-13.</div>

Stem Cells International

fig7

Figure 7

Figure 7: VCAM-1 Promotes Angiogenesis of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Trauma-Induced Osteonecrosis of the Femoral Head by Regulating the Apelin/CCN2 Pathway 

Figure 7 | VCAM-1 Promotes Angiogenesis of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Trauma-Induced Osteonecrosis of the Femoral Head by Regulating the Apelin/CCN2 Pathway 